Replication of Legionella Pneumophila in Human Cells: Why are We Susceptible? by Arwa Abu Khweek & Amal Amer
www.frontiersin.org December 2010 | Volume 1 | Article 133 | 1
Review ARticle
published: 28 December 2010
doi: 10.3389/fmicb.2010.00133
Replication of Legionella pneumophila in human cells: why 
are we susceptible?
Arwa Abu Khweek and Amal Amer*
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Center for Microbial Interface Biology and the Department of Internal Medicine, Ohio State University, 
Columbus, OH, USA
Legionella pneumophila is the causative agent of Legionnaires’ disease, a serious and often fatal 
form of pneumonia. The susceptibility to L. pneumophila arises from the ability of this intracellular 
pathogen to multiply in human alveolar macrophages and monocytes. L. pneumophila also 
replicates in several professional and non-professional phagocytic human-derived cell lines. 
With the exception of the A/J mouse strain, most mice strains are restrictive, thus they do 
not support L. pneumophila replication. Mice lacking the NOD-like receptor Nlrc4 or caspase-1 
are also susceptible to L. pneumophila. On the other hand, in the susceptible human hosts, 
L. pneumophila utilizes several strategies to ensure intracellular replication and protect itself 
against the host immune system. Most of these strategies converge to prevent the fusion of 
the L. pneumophila phagosome with the lysosome, inhibiting host cell apoptosis, activating 
survival pathways, and sequestering essential nutrients for replication and pathogenesis. In 
this review, we summarize survival mechanisms employed by L. pneumophila to maintain 
its replication in human cells. In addition, we highlight different human-derived cell lines that 
support the multiplication of this intracellular bacterium. Therefore, these in vitro models can 
be applicable and are reproducible when investigating L. pneumophila/phagocyte interactions 
at the molecular and cellular levels in the human host.
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and are required for replication of biofilm-associated L. pneumophila 
(Rowbotham, 1980, 1986; Nash et al., 1984; Kuiper et al., 2004). While 
providing a niche for L. pneumophila replication, amoebae also protect 
L. pneumophila from harsh environmental conditions. Replication 
within different protozoa enhances bacterial multiplication in human 
alveolar macrophages. Growth within the protozoa also induces resist-
ance to chemical disinfectant, biocides and antibiotics and induces 
phenotypic changes in L. pneumophila (Barker et al., 1992, 1995; Abu 
Kwaik et al., 1993; Cirillo et al., 1994).
Risk factoRs
The majority of people exposed to L. pneumophila remains asymp-
tomatic or suffer only mild self-limiting infection. Susceptible 
patients to LD disease are likely to exhibit a defect in cell-mediated 
immunity rendering them less capable of limiting the early multi-
plication of L. pneumophila. Cigaret smoking, chronic lung disease, 
and immunosuppression (especially that caused by corticosteroid 
therapy) have been consistently implicated as risk factors (Carratala 
et al., 1994). Surgery is a major predisposing factor in nosocomial 
infection, with transplant recipients at highest risk. Other factors 
associated with the development of LD include, old age, cancer, and 
alcohol intake (Marston et al., 1994; Den Boer et al., 2002).
L. pneumophiLa multiplies in human monocytes, 
alveolaR macRophages, and human-deRived cell lines
Legionella pneumophila multiplies in human monocytes (Horwitz 
and Silverstein, 1980; Horwitz, 1983b). The intracellular fate of 
L.  pneumophila in both human and protozoa is similar, where the 
LegioneLLa pneumophiLa
Legionella pneumophila is a facultative intracellular lung patho-
gen (Horwitz and Silverstein, 1980) and the causative agent of 
Legionnaires’ disease (LD), a serious and often fatal, life-threaten-
ing bacterial pneumonia. LD is also a relatively common cause of 
community-acquired and nosocomial pneumonia in adults. L. pneu-
mophila was recognized in 1976 after an outbreak of pneumonia at 
an American Legion convention in Philadelphia. Soon after, the 
etiologic agent was identified as a fastidious Gram-negative bacil-
lus and named L. pneumophila. Although several other species of 
the genus Legionella were subsequently identified, the great majority 
of LD is caused by L. pneumophila (Marston et al., 1997; Yu et al., 
2002). Most nosocomial infections and hospital outbreaks have been 
linked to contaminated air or water supplies. L. pneumophila has been 
recovered from different aquatic habitats including showers, streams, 
whirlpools, air conditioners, cooling towers, fountains, and spa baths 
(Fraser et al., 1979; Fliermans et al., 1981; Sethi and Brandis, 1983; 
Spitalny et al., 1984; Lettinga et al., 2002). Within water systems, L. 
pneumophila colonizes into biofilm; which are complex bacterial com-
munities attached to a substratum by means of exopolysaccharides 
(EPS; Rogers et al., 1994). Biofilm develop into mushroom-like struc-
tures with water channels that allow access to nutrients and oxygen 
within these bacterial communities. L. pneumophila is able to obtain 
nutrients such as amino acids and organic carbon sources from the 
microbial consortium located in the biofilm (Watnick and Kolter, 
2000). Humans are accidental dead-end hosts for L. pneumophila, 
thus, there is no person-to-person transmission whereas, protozoa are 
considered the environmental hosts for this intracellular pathogen, 
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vacuole (LCV) remains studded with ribosomes until hundreds of 
the bacteria fill the vacuole and the monocyte ruptures (Figure 1; 
Nash et al., 1984). In contrast, formalin-killed L. pneumophila does 
not inhibit fusion or induce the formation of specialized phago-
some and the dead bacteria are degraded within the phagolysosome 
(Horwitz and Silverstein, 1980; Horwitz, 1983b).
Alveolar macrophages are the most abundant potential effector 
cells in the lung and play a role in host defense against L.  pneumophila 
(Nash et al., 1984). L. pneumophila that reaches the alveoli encoun-
ters and multiplies in human alveolar macrophages at the site of 
infection, which is crucial to the pathogenesis of LD (Green, 1970; 
Goldstein et al., 1974). Lung tissue specimens from LD patients 
frequently contain large numbers of intracellular L. pneumophila 
(Winn Jr. and Myerowitz, 1981; Nash et al., 1984). Furthermore, 
alveolar macrophages are a major feature of the alveolar secretions 
in lung biopsies from patients with LD (Winn Jr. and Myerowitz, 
1981; Nash et al., 1984).
bacteria evade fusion of the phagosome to lysosome, although the 
mechanism maybe different in some aspects (Horwitz, 1983a,b; 
Horwitz and Maxfield, 1984; Bozue and Johnson, 1996). Attachments 
and binding of L. pneumophila to the complement receptor 1 (CR1), 
and complement receptor 3 (CR3) on human phagocytic cells is fol-
lowed by entry into these cells. In some cases, the entry of the patho-
gen is mediated by “coiling phagocytosis,” in which a single long 
phagocyte pseudopod coils around the bacterium as it is internal-
ized (Horwitz, 1984; Payne and Horwitz, 1987; Figure 1). Following 
phagocytosis, L. pneumophila avoids interaction with endosomes, 
early and late lysosomes, and instead, fuses transiently with mito-
chondria and intercepts the endoplasmic reticulum (ER) exit vesicles 
(Horwitz, 1983b; Swanson and Isberg, 1995; Kagan and Roy, 2002; 
Liang et al., 2006; Isberg et al., 2009). The bacteria maintain interac-
tions with ER-derived vesicles and replicate in a vacuole surrounded 
by a membrane that resembles rough ER (Horwitz and Silverstein, 
1980; Horwitz, 1983b; Figure 1). The L. pneumophila-containing 
Figure 1 | Diagram depicting survival mechanisms employed by 
L. pneumophila in human phagocytes. Upon entry into a human phagocyte, 
L. pneumophila becomes contained into a vacuole called Legionella-containing 
phagosome that avoids the typical fusion with the lysosome, and instead 
remodels into an ER-like vesicle allowing bacterial replication (1). L. pneumophila 
promotes the cleavage of Rabaptin-5 by caspase-3, thus preventing the default 
phagosome–lysosome fusion (2). L. pneumophila does not activate caspase-1 
and -7 in human monocytes, consequently aborting the phagosome–lysosome 
fusion (3). This pathogen inhibits host cell apoptosis by up regulating anti-
apoptotic genes (4). L. pneumophila controls the local balance of activating 
cytokines (INF-γ, TNF-α) that inhibit its replication, and inhibiting cytokines (IL-10) 
that allow its survival (5). L. pneumophila activates the NF-κB pathway to 
maintain host cell survival (6). L. pneumophila modulates other innate immune 
responses to establish a replicative niche (7).
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L. pneumophila pathogenesis. While some features are unique to 
the interactions between L. pneumophila and specific host cells, the 
primary mechanisms of infection appears to be the same.
the innate immune Response of pRimaRy human cells 
and human-deRived cell lines to L. pneumophiLa
Host cells express a range of receptors that act as microbial sen-
sors. These receptors sense microorganisms and transduce signals 
that activate immune responses. Pathogen-associated molecular 
patterns (PAMPs) such as peptidoglycan, bacterial flagellin, and 
nucleic acid can be recognized by means of cell surface pattern 
recognition receptors (PRRs) named Toll-like receptors (TLRs) 
(Underhill et al., 1999; Janeway Jr. and Medzhitov, 2002; Takeda 
et al., 2003). TLRs recognize PAMPs via an extracellular domain and 
initiate inflammatory signaling pathways through an intracellular 
domain (Underhill et al., 1999; Janeway Jr. and Medzhitov, 2002; 
Takeda et al., 2003). Humans express functional TLRs 1–10 whereas 
mice express TLRs 1–7 and 9–13 (Table 1; Vinzing et al., 2008).
Other means of sensing the presence of microbes or their fac-
tors in the host cytosol is mediated by NOD-like receptors (NLRs), 
which in turn, initiate signaling cascades that mediate the produc-
tion of inflammatory cytokines, recruitment of phagocytic cells 
and direction of the innate and the acquired immune responses. 
There are 23 NLRs in human and 34 in mice (Abdelaziz et al., 
2010; Amer, 2010). Typically, NLRs are composed of a leucine-rich 
repeat (LRR) domain, a central nucleotide oligomerization domain 
(NOD) and N-terminal effector binding domain, which consists of 
caspase recruitment domain (CARD) and the pyrin domain.
One of the major NLRs contributing to the restriction of 
L. pneumophila infection in human and in mice is NLRC4 (IPAF) 
(Damiano et al., 2001; Poyet et al., 2001; Amer et al., 2006; Vinzing 
et al., 2008; Akhter et al., 2009). Human NLRC4 is highly homolo-
gous to the mouse Nlrc4 and is expressed in human macrophages 
but not in human lung epithelial cells (Vinzing et al., 2008). Like 
most NLRs, mouse Nlrc4 assembles in a large multiprotein com-
plex called the inflammasome leading to the activation of cas-
pase-1. Caspases are family of cysteine proteases that play a distinct 
role in apoptosis and inflammation (Fink and Cookson, 2005). 
Caspases can be divided into two groups; one category of caspases 
is involved in apoptosis such as caspase-3 and -7 (Martinon and 
Tschopp, 2004). Another category is involved in inflammation and 
is required for cytokine processing (Creagh et al., 2003). As an 
inflammatory caspase, caspase-1 is required for the activation of 
cytokines such as IL-1β, IL-18, and IL-33 and induces a form of 
cell death named pyroptosis (Fink and Cookson, 2005).  Wild-type 
Beside human monocytes and alveolar macrophages, inves-
tigators have employed a variety of cell lines that not only have 
similar characteristics to human phagocytes, but are also capable 
of supporting growth of this intracellular pathogen. For example, 
L. pneumophila multiplies within and kills HL-60 cells, a mac-
rophage-like cell line that is derived from promyelocyte (Marra 
et al., 1990). In HL-60 cells, L. pneumophila enters by adhering to 
the CR3 and is taken by coiling phagocytosis. Similar to human 
phagocytes, the LCV is surrounded by ER-derived vesicles studded 
with ribosomes and therefore, HL-60 cells are utilized as a model 
to study the interaction of human macrophages with the LD bac-
terium (Marra et al., 1990). Similarly, L. pneumophila grows within 
U937 cells; a human monocytes lymphoma cell line that displays 
many monocytic features and can be maintained continuously in 
culture (Pearlman et al., 1988). These cells can be differentiated 
to adherent, non-replicative cells with characteristics of tissue 
macrophages. Additionally, they express surface markers specific 
for cells of monocyte lineage and are able to differentiate between 
virulent and avirulent strains of L. pneumophila. Their activation 
state is controlled experimentally and consequently can be stand-
ardized (Rovera et al., 1979). THP-1 is another human monocytic 
cell line that matures into macrophage-like adherent cells follow-
ing stimulation with phorbol esters or 1,25-dihydroxyvitamin D3. 
Cirillo et al. (1994) reported that L. pneumophila could invade 
and multiply within THP-1 cells in a manner similar to that in 
human monocytes and macrophages. Mono Mac 6 (MM6) is an 
additional example of human monocytic cell line. MM6 was gener-
ated from peripheral blood of patient with monoblastic leukemia. 
Phenotypically and functionally, MM6 represents a more mature 
macrophage-like cell line. Unlike the other monoblastic cell lines 
U937 and THP-1, MM6 does not require stimulation by phorbol 
esters or 1,25-dihydroxyvitamin D3 and expresses several mark-
ers that are lacking in U937 and THP-1 (Ziegler-Heitbrock et al., 
1988; Neumeister et al., 1997). MM6 has been successfully utilized 
to study the molecular pathogenesis of L. pneumophila and other 
intracellular pathogens that can replicate within human monocytes 
(Neumeister, 2004). Furthermore, non-professional phagocytic cell 
lines have been utilized to study L. pneumophila replication such as 
A549, a human epithelial cell line derived from a human lung can-
cer. They are non-professional phagocytes and have characteristics 
of type II alveolar epithelial cells (Maruta et al., 1998). It has been 
shown that L. pneumophila is internalized and replicate effectively 
in A549 cells (Maruta et al., 1998; Vinzing et al., 2008; Bartfeld 
et al., 2009). Therefore, many human-derived cell lines have been 
used to characterize the molecular mechanisms associated with 
Table 1 | Differences between human and mice cells that affects Legionella permissiveness.
 Human Mice references
TLRs 1–10 1–7 and 9–13 Akira et al. (2006 #137)
NLRs 23 members 34 members Abdelaziz et al. (2010 #149)
NAIPs 1 7 paralogs Vinzing et al. (2008 #7)
Caspases 11 caspases 10 caspases 
Caspase-1 Not activated in response to Legionella infection Activated in response to Legionella infection Akhter et al. (2009 #5)
Caspase-7 Not activated in response to Legionella infection Activated in response to Legionella infection Akhter et al. (2009 #5)
Caspase-3 activated in response to Legionella infection Not activated in response to Legionella infection Santic et al. (2007 #8)
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the Role of caspase-3 in L. pneumophiLa infection of 
human cells
The host can employ several mechanisms to overcome intracel-
lular infection. Among these, is the elimination of infected cells 
by caspase-mediated apoptosis. Arising reports demonstrate new 
distinct roles for executioner caspases independent of cell death (Li 
and Yuan, 2008; Walsh et al., 2008; Amer, 2010). L. pneumophila 
induces caspase-3 activation in human macrophages and U937 
(Gao and Abu Kwaik, 1999a,b; Zink et al., 2002; Molmeret et al., 
2004; Santic et al., 2007). The earlier studies with macrophages and 
epithelial cells demonstrated that high numbers of L. pneumophila 
induces apoptosis through activation of caspase-3 (Gao and Abu 
Kwaik, 1999a; Neumeister et al., 2001). Remarkably, other studies 
demonstrated that the early caspase-3 activation by L. pneumophila 
is independent of the intrinsic and extrinsic pathways of apoptosis 
(Molmeret et al., 2004). Notably, at physiological levels of infec-
tion, L. pneumophila utilizes the early mild caspase-3 activation in 
human cells to evade the phagosome–lysosome fusion. Activation 
of caspase-3 by low numbers of L. pneumophila is accompanied with 
cleavage of rabaptin-5, a downstream effector of rab-5 (Molmeret 
et al., 2004). Rab-5 GTPase is involved in the maturation of the 
early endosome. Therefore, according to the number of L. pneu-
mophila invading a human cell, caspase-3 activation can lead either 
to apoptosis or to delayed phagosome maturation.
modulation of the ubiquitination machineRy by 
L. pneumophiLa
Several studies showed that in human cells, the LCV is decorated with 
polyubiquitinated proteins upon L. pneumophila infection (Ivanov 
and Roy, 2009). Ubiquitination is a reversible post- translational 
modification that controls the abundance of many critical regulatory 
proteins (Craig and Tyers, 1999; Lomma et al., 2010). Degradation 
of intracellular proteins is mediated via means of the ubiquitin 
system and its specificity is determined at the level of substrate 
recognition by the E3 ubiquitin ligases, that catalyzes binding of 
the activated ubiquitin to the target protein for degradation (Craig 
and Tyers, 1999). Additionally, the L. pneumophila genome encodes 
for proteins with F-box and U-box domains (Cazalet et al., 2004; 
Price et al., 2009; Lomma et al., 2010) that are similar to eukaryotic 
SCF ubiquitin ligases. F-box proteins are known components of E3 
ubiquitin ligases named SCF complexes. The F-box motif within 
the F-box protein interacts with the components of the ubiquitin 
machinery while the protein–protein interaction domain selectively 
binds to specific substrate. The U-box is a domain of approximately 
70 amino acids that is present in proteins from yeast to humans. 
Mammalian U-box proteins in conjugation with E1 and E2 mediate 
protein ubiquitination, and thus have been classified as E3 ligases 
(Hatakeyama et al., 2001). Three F-box-containing proteins have 
been shown to be required for intracellular replication of L. pneu-
mophila in THP-1 macrophages and A549 cells, and single, double, 
or triple mutations in the F-box proteins impair infection within 
these cells (Lomma et al., 2010). Al-Khodor et al. (2008) showed 
that the F-box-containing protein AnkB is required for intracellular 
replication of L. pneumophila within human monocytes-derived 
macrophages (hMDM). Furthermore, AnkB translocated to the 
host cytosol via the type IV secretion system mediates L. pneu-
mophila replication via  decorating the LCV with polyubiquitinated 
mouse macrophages restrict L. pneumophila  replication via caspase-
1-mediated caspase-7 activation resulting in fusion of the LCV with 
the lysosome leading to bacterial degradation and growth restric-
tion (Akhter et al., 2009). However, human monocytes do not 
activate caspase-1 and -7 upon L. pneumophila infection, allowing 
bacterial growth (Table 1; Santic et al., 2007; Akhter et al., 2009). 
Although THP-1 cells were not shown to activate caspase-1 in 
response to L. pneumophila, the depletion of human NLRC4 allows 
more L. pneumophila replication (Vinzing et al., 2008). This data 
implies the existence of uncharacterized caspase-1-independent 
restriction mechanism of L. pneumophila replication in human 
phagocytes.
A subset of NLRs contains baculovirus inhibitor of apoptosis 
repeat domains (BIR) instead of CARD or pyrin domains. These 
proteins are called the neuronal apoptosis-inhibitory proteins 
(NAIPs). The LRR domain recognizes microbial products, while 
the BIR domains are essential for their interactions with caspase-3 
and -7 (Liston et al., 1996; Takahashi et al., 1998; Diez et al., 
2003). The importance of Naip5 during L. pneumophila infection 
stemmed from studies showing that the A/J mice are permissive 
to L. pneumophila in contrast to most other inbred mouse strains 
(Diez et al., 2003; Wright et al., 2003). Gros and his group identified 
14 amino acid substitutions in the A/J derived Naip5 when com-
pared to wild-type Naip5 and they proposed that several of these 
mutations are responsible for permissiveness to L. pneumophila 
(Beckers et al., 1995; Diez et al., 2003). Furthermore, in contrast 
to the seven mouse Naips, only one NAIP has been identified in 
human and exhibits 68% homology to the mouse C57BL/6 and 
A/J Naip5. Human NAIP is expressed in THP-1, primary macro-
phages, and A549 epithelial cells. Furthermore, depletion of the 
human orthologs of Naip5 results in increased replication of L. 
pneumophila in human THP-1 macrophages and A549 lung epi-
thelial cells (Vinzing et al., 2008). However, the mechanism by 
which human NAIP restricts L. pneumophila replication is yet to 
be elucidated.
the activation of suRvival pathways in 
L. pneumophiLa-infected human cells
Studies with the human macrophage-like U937 and human epithe-
lial cells A549 showed that L. pneumophila induces the activation 
of the transcriptional regulator nuclear factor κB (NF-κB) upon 
infection (Losick and Isberg, 2006; Abu-Zant et al., 2007; Schmeck 
et al., 2007; Bartfeld et al., 2009). L. pneumophila induces biphasic 
activation of the NF-κB pathway. The early phase is strong, but 
transient and is flagellin, TLR5 and MYD88-dependent. It is termi-
nated quickly to prevent the autotoxic overproduction of inflam-
matory mediators. L. pneumophila activates the NF-κB pathway 
in human epithelial cells leading to secretion of several cytokines 
and chemokines (Schmeck et al., 2007). This activation is benefi-
cial for the host since it triggers the innate immune response. The 
second phase of NF-κB activation is characterized by long-term 
activation for up to 30 h. However, this phase is flagellin, TLR5, 
MYD88-independent (Bartfeld et al., 2009). The long-term activa-
tion of NF-κB is linked to bacterial replication and upregulation of 
anti-apoptotic genes (Bartfeld et al., 2009). Therefore, this phase 
seems to be beneficial for the pathogen. The mechanism for this 
late stage NF-κB activation is still unclear.
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However, patients with acute LD are able to restrict L. pneumophila 
replication as a result elevated level of the Th1-cytokines such as 
INF-γ and IL-12 (Takeda et al., 2003). Sera from patients with 
L. pneumophila contain antibodies to L. pneumophila protein anti-
gens (Friedman et al., 2002). However, humoral immunity seems 
to play a limited role in host defense against LD. Horwitz and 
Silverstein (1981a) demonstrated that complement and antibody, 
which promote entry of L. pneumophila into monocytes, do not 
inhibit the rate of L. pneumophila multiplication in monocytes.
otheR immune Responses to L. pneumophiLa in 
human cells
Another major strategy of innate resistance to intracellular infec-
tion is to sequester key nutrients, such as iron, from invading bac-
teria. Within host cells, iron is predominantly bound to proteins 
and unavailable in free soluble form. Under iron-limited condi-
tions, L. pneumophila secretes a high affinity iron chelator named 
siderophore, which sequesters iron from the host and the surround-
ing environment (Liles et al., 2000; Cianciotto, 2007). L. pneumophila 
utilizes iron to maintain its replication in human monocytes and 
macrophages. Consistently, treatment of human monocytes and 
macrophages with iron chelator aborts L. pneumophila replica-
tion (Gebran et al., 1994; Viswanathan et al., 2000). Accordingly, 
restrictive monocytes seem to exhibit low level of expression of 
transferrin receptor similar to the low level of expression of trans-
ferrin receptor in INF-γ activated monocytes (Byrd and Horwitz, 
2000). Consequently, supplementation of iron abolishes the effect 
of INF-γ-mediated growth restriction of L. pneumophila in hMDM 
(Santic et al., 2005).
Bacterial infection stimulates the production of reactive nitro-
gen intermediate by the inducible nitric oxide synthase (iNOS). 
Transcription of NOS2 is mediated by type I and type II interfer-
ons; suggesting that the production of nitric oxide (NO) is not an 
immediate response for the infection. NO mediates its action on 
bacteria in the vacuole or the cytosol. However, stimulation with 
1,25-dihydroxyvitamin D(3) to enhance NO production or the 
inhibition of NO production by treatment with N(G)-methyl-l-
arginine did not modify the intracellular multiplication of L. pneu-
mophila within MM6. This study suggested that NO radicals do 
not play a role in restricting different L. pneumophila species in 
human monocytic cell lines (Neumeister et al., 2001). So far, the role 
of NO radicals in human macrophages seems to be controversial 
(Neumeister et al., 2001; Radtke and O’Riordan, 2006).
genetic susceptibility to legionnaiRes’ disease
While the genetic factors that predispose individuals for LD are 
not well known, it has been shown that TLR5 influences human 
susceptibility to L. pneumophila infection. TLR5 recognizes bacte-
rial flagellin (Hayashi et al., 2001) and is the predominant mediator 
of Interleukin-8 (IL-8) in lung epithelial cells A549. A common 
stop codon polymorphism in the ligand-binding domain of TLR5 
(TLR5329STOP) occurs in 10% of the population resulting in the ina-
bility to mediate flagellin signaling and is associated with increased 
risk to LD (Hawn et al., 2003). TLR5329STOP has a dominant nega-
tive effect and peripheral blood monocytes (PBMCs) from hetero-
zygous individuals stimulated with flagellin had less IL-6 and IL-8 
secretion. Likely, TLR5329STOP mutation increases susceptibility to 
proteins (Price et al., 2009). The focal adhesion protein ParvB, is 
the target for AnkB (Lomma et al., 2010), and AnkB interferes 
with the ubiquitination of the ParvB, likely by competing with the 
eukaryotic E3 ligase for the protein–protein interaction domain of 
ParvB (Lomma et al., 2010). Therefore, L. pneumophila hijacks the 
host cell ubiquitination system to mediate intracellular replication 
in human cells.
the Role of cytokines duRing L. pneumophiLa 
infection in human cells
Other innate immune mechanisms might modulate L. pneumophila 
infection in human cells, including cytokine production such as 
Interferon gamma-γ (INF-γ) and Tumor necrosis-α (TNF-α) 
(Coers et al., 2007). Induction of innate immunity includes mac-
rophage activation by the antimicrobial cytokine IFN-γ, protection 
by TNF-α, and production of IL-6 and IL-1, as well as chemokines 
from inflammatory cells (Friedman et al., 2002). In vitro studies 
with primary human macrophages or cell lines derived from human 
macrophages that are activated with INF-γ and TNF-α restricted 
L. pneumophila replication (Bhardwaj et al., 1986; Nash et al., 
1988; Matsiota-Bernard et al., 1993). Furthermore, pretreatment 
of hMDM with INF-γ inhibited intracellular replication of L. pneu-
mophila and restricted the multiplication of the pathogen (Santic 
et al., 2005). The authors speculate that these processes are distinct 
between human and mouse macrophages and ultimately determine 
the permissiveness to L. pneumophila. TNF-α has been detected in 
the broncho-alveolar lavage fluid during L. pneumophila infection 
(Blanchard et al., 1987). It is produced readily by human periph-
eral blood lymphocytes in response to L. pneumophila antigens 
(Friedman et al., 2002). TNF-α is a potent cytokine that enhances 
the bactericidal activity of the macrophages. Furthermore, inhibi-
tion of TNF-α production is associated with increased bacterial 
replication (Nash et al., 1984; Matsiota-Bernard et al., 1993).
In contrast to the macrophage activating cytokines INF-γ and 
TNF-α, Interleukin-10 (IL-10) is an inhibitory cytokine. IL-10 
treatment significantly enhances L. pneumophila growth in mono-
cytes, and completely reverses the protective effect of INF-γ on 
L. pneumophila replication (Park and Skerrett, 1996). IL-10 has 
similar, but less potent, effects on alveolar macrophages and INF-
γ-activated alveolar macrophages are less sensitive to deactivation 
by IL-10. Park and Skerrett (1996) identified important differences 
in alveolar macrophages and monocytes response to L. pneumophila 
infection and to IL-10. They also suggested that the induction of 
IL-10 during L. pneumophila infection may be a virulence mecha-
nism that promotes intracellular bacterial replication. Therefore, 
the local balance between the INF-γ and IL-10 production by 
L. pneumophila might determine if monocytes that are recruited 
to the site of infection will become effector cells or develop into 
susceptible targets available for bacterial growth.
Cell-mediated immunity seems to play a critical role in restrict-
ing L. pneumophila replication, and the activated human mono-
cytes have the capacity to inhibit the multiplication of virulent 
L. pneumophila both via decreasing the phagocytosis and the rate 
of intracellular multiplication (Horwitz and Silverstein, 1981b). 
Consistent with that, patients with LD produce less INF-γ than 
non-LD patients, suggesting that impairment in the INF-γ response 
may increase the susceptibility to the disease (Lettinga et al., 2003). 
Frontiers in Microbiology | Cellular and Infection Microbiology  December 2010 | Volume 1 | Article 133 | 6
Khweek and Amer The interaction of Legionella pneumophila with phagocytes
factor by Legionella pneumophila. 
Infect. Immun. 55, 433–437.
Bozue, J. A., and Johnson, W. (1996). 
Interaction of Legionella pneumophila 
with Acanthamoeba castellanii: uptake 
by coiling phagocytosis and inhibition 
of phagosome–lysosome fusion. Infect. 
Immun. 64, 668–673.
Byrd, T. F., and Horwitz, M. A. (2000). 
Aberrantly low transferrin receptor 
expression on human monocytes is 
associated with nonpermissiveness 
for Legionella pneumophila growth. J. 
Infect. Dis. 181, 1394–1400.
Carratala, J., Gudiol, F., Pallares, R., Dorca, 
J., Verdaguer, R., Ariza, J., and Manresa, 
F. (1994). Risk factors for nosocomial 
Legionella pneumophila pneumonia. 
Am. J. Respir. Crit. Care Med. 149(Pt 
1), 625–629.
Cazalet, C., Rusniok, C., Brüggemann, 
H., Zidane, N., Magnier, A., Ma, L., 
Tichit, M., Jarraud, S., Bouchier, C., 
Vandenesch, F., Kunst, F., Etienne, J., 
Glaser, P., and Buchrieser, C. (2004). 
Evidence in the Legionella pneu-
mophila genome for exploitation of 
host cell functions and high genome 
plasticity. Nat. Genet. 36, 1165–1173.
Cianciotto, N. P. (2007). Iron acquisition 
by Legionella pneumophila. Biometals 
20, 323–331.
Cirillo, J. D., Falkow, S., and Tompkins, L. 
S. (1994). Growth of Legionella pneu-
mophila in Acanthamoeba castellanii 
enhances invasion. Infect. Immun. 62, 
3254–3261.
Coers, J., Vance, R. E., Fontana, M. F., and 
Dietrich, W. F. (2007). Restriction of 
Legionella pneumophila growth in 
macrophages requires the concerted 
action of cytokine and Naip5/Ipaf 
signalling pathways. Cell. Microbiol. 
9, 2344–2357.
Amer, A. O. (2010). Modulation of cas-
pases and their non-apoptotic func-
tions by Legionella pneumophila. Cell. 
Microbiol. 12, 140–147.
Archer, K. A., Alexopoulou, L., Flavell, 
R. A., and Roy, C. R. (2009). Multiple 
MyD88-dependent responses con-
tribute to pulmonary clearance 
of Legionella pneumophila. Cell. 
Microbiol. 11, 21–36.
Barker, J., Brown, M. R., Collier, P. J., Farrell, 
I., and Gilbert, P. (1992). Relationship 
between Legionella pneumophila and 
Acanthamoeba polyphaga: physi-
ological status and susceptibility to 
chemical inactivation. Appl. Environ. 
Microbiol. 58, 2420–2425.
Barker, J., Scaife, H., and Brown, M. 
R. (1995). Intraphagocytic growth 
induces an antibiotic-resistant phe-
notype of Legionella pneumophila. 
Antimicrob. Agents Chemother. 39, 
2684–2688.
Bartfeld, S., Engels, C., Bauer, B., Aurass, 
P., Flieger, A., Bruggemann, H., and 
Meyer, T. F. (2009). Temporal resolu-
tion of two-tracked NF-kappaB acti-
vation by Legionella pneumophila. Cell. 
Microbiol. 11, 1638–1651.
Beckers, M. C., Yoshida, S., Morgan, K., 
Skamene, E., and Gros, P. (1995). 
Natural resistance to infection with 
Legionella pneumophila: chromosomal 
localization of the Lgn1 susceptibility 
gene. Mamm. Genome 6, 540–545.
Bhardwaj, N., Nash, T. W., and Horwitz, 
M. A. (1986). Interferon-gamma-
activated human monocytes inhibit 
the intracellular multiplication of 
Legionella pneumophila. J. Immunol. 
137, 2662–2669.
Blanchard, D. K., Djeu, J. Y., Klein, T. 
W., Friedman, H., and Stewart, W. E. 
(1987). Induction of tumor necrosis 
RefeRences
Abdelaziz, D. H., Amr, K., and Amer, A. O. 
(2010). Nlrc4/Ipaf/CLAN/CARD12: 
more than a flagellin sensor. Int. J. 
Biochem. Cell Biol. 42, 789–791.
Abu Kwaik, Y., Eisenstein, B. I., and 
Engleberg, N. C. (1993). Phenotypic 
modulation by Legionella pneumophila 
upon infection of macrophages. Infect. 
Immun. 61, 1320–1329.
Abu-Zant, A., Jones, S., Asare, R., Suttles, J., 
Price, C., Graham, J., and Kwaik, Y. A. 
(2007). Anti-apoptotic signalling by the 
Dot/Icm secretion system of L. pneu-
mophila. Cell. Microbiol. 9, 246–264.
Akhter, A., Gavrilin, M. A., Frantz, L., 
Washington, S., Ditty, C., Limoli, 
D., Day, C., Sarkar, A., Newland, C., 
Butchar, J., Marsh, C. B., Wewers, M. 
D., Tridandapani, S., Kanneganti, 
T.-D., and Amer, A. O. (2009). 
Caspase-7 activation by the Nlrc4/
Ipaf inflammasome restricts Legionella 
pneumophila infection. PLoS Pathog. 
5, e1000361. doi: 10.1371/journal.
ppat.1000361.
Akira, S., Uematsu, S., and Takeuchi, O. 
(2006). Pathogen recognition and 
innate immunity. Cell 124, 783–801.
Al-Khodor, S., Price, C. T., Habyarimana, 
F., Kalia, A., and Abu Kwaik, Y. (2008). 
A Dot/Icm-translocated ankyrin 
protein of Legionella pneumophila is 
required for intracellular proliferation 
within human macrophages and pro-
tozoa. Mol. Microbiol. 70, 908–923.
Amer, A., Franchi, L., Kanneganti, T. D., 
Body-Malapel, M., Ozören, N., Brady, 
G., Meshinchi, S., Jagirdar, R., Gewirtz, 
A., Akira, S., and Núñez, G. (2006). 
Regulation of Legionella phagosome 
maturation and infection through 
flagellin and host Ipaf. J. Biol. Chem. 
281, 35217–35223.
Craig, K. L., and Tyers, M. (1999). The 
F-box: a new motif for ubiquitin 
dependent proteolysis in cell cycle 
regulation and signal transduc-
tion. Prog. Biophys. Mol. Biol. 72, 
299–328.
Creagh, E. M., Conroy, H., and Martin, S. 
J. (2003). Caspase-activation pathways 
in apoptosis and immunity. Immunol. 
Rev. 193, 10–21.
Damiano, J. S., Stehlik, C., Pio, F., Godzik, 
A., and Reed, J. C. (2001). CLAN, a 
novel human CED-4-like gene. 
Genomics 75, 77–83.
Den Boer, J. W., Yzerman, E. P., Schellekens, 
J., Lettinga, K. D., Boshuizen, H. C., Van 
Steenbergen, J. E., Bosman, A., Van den 
Hof, S., Van Vliet, H. A., Peeters, M. 
F., Van Ketel, R. J., Speelman, P., Kool, 
J. L., and Conyn-Van Spaendonck, 
M. A. (2002). A large outbreak of 
Legionnaires’ disease at a flower show, 
the Netherlands, 1999. Emerging Infect. 
Dis. 8, 37–43.
Diez, E., Lee, S. H., Gauthier, S., Yaraghi, 
Z., Tremblay, M., Vidal, S., and Gros, 
P. (2003). Birc1e is the gene within the 
Lgn1 locus associated with resistance 
to Legionella pneumophila. Nat. Genet. 
33, 55–60.
Fink, S. L., and Cookson, B. T. (2005). 
Apoptosis, pyroptosis, and necrosis: 
mechanistic description of dead and 
dying eukaryotic cells. Infect. Immun. 
73, 1907–1916.
Fliermans, C. B., Cherry, W. B., Orrison, L. 
H., Smith, S. J., Tison, D. L., and Pope, 
D. H. (1981). Ecological distribution of 
Legionella pneumophila. Appl. Environ. 
Microbiol. 41, 9–16.
Fraser, D. W., Deubner, D. C., Hill, D. L., and 
Gilliam, D. K. (1979). Nonpneumonic, 
short-incubation-period Legionellosis 
(Pontiac fever) in men who cleaned a 
was restored at convalescence. However, the deficiency of lectin 
pathway seems to be an effect rather than a risk factor for LD 
development (Herpers et al., 2009).
conclusions
Legionella pneumophila exploits several strategies to overcome the 
innate immune defense in human phagocytes (Figure 1). However, 
most of these converge toward preventing the fusion of its phago-
some with the lysosome, inhibiting host cell apoptosis, maintaining 
host cell survival, modulating the local balance between activating 
and inhibiting cytokines, sequestering nutrients from the host and 
overcoming the killing mechanisms available within phagocytes.
acknowledgments
We thank Kyle Caution for editing the manuscript and Dr. Tim 
Eubank for the figure. Studies in Dr. Amal Amer laboratory are 
supported by grants R01HL094586 and R21AI083871 from the 
National Institute of Health (NIH) and GRT00013604 from the 
American Lung Association (ALA).
LD by decreasing the cytokine secretion. However, the role of the 
mouse TLR5 in L. pneumophila infection is controversial (Hawn 
et al., 2007; Archer et al., 2009). On the other hand, polymorphism 
in the TLR4 receptor, SNP A896G, is associated with resistance to 
LD in heterozygous individuals (Hawn et al., 2005).
Another factor associated with resistance to L. pneumophila 
infection is the mannose-binding lectin (MBL), a PRR of the 
innate immune system that activates complement via the lectin 
pathway (Turner, 1996). MBL deficiency compromises opsoni-
zation by complement leading to an increased risk of infection. 
In infection with intracellular pathogens, the role of MBL defi-
ciency is more ambiguous, as more intracellular pathogens use 
opsonization by MBL to enter their host cell. Herpers et al. (2009) 
showed that Legionellosis is not associated with MBL deficiency. 
However, a large number of patients with Legionellosis displayed 
deficient MBL-mediated complement activation even though 
they carried MBL-sufficient genotypes. Furthermore, patients 
with MBL-sufficient genotypes showed functional deficiency at 
the acute phase of disease, yet the lectin pathway functionality 
www.frontiersin.org December 2010 | Volume 1 | Article 133 | 7
Khweek and Amer The interaction of Legionella pneumophila with phagocytes
Marston, B. J., Plouffe, J. F., File, T. M., 
Jr., Hackman, B. A., Salstrom, S. J., 
Lipman, H. B., Kolczak, M. S., and 
Breiman, R. F. (1997). Incidence of 
community-acquired pneumonia 
requiring hospitalization. Results of a 
population-based active surveillance 
Study in Ohio. The Community-Based 
Pneumonia Incidence Study Group. 
Arch. Intern. Med. 157, 1709–1718.
Martinon, F., and Tschopp, J. (2004). 
Inflammatory caspases: linking an 
intracellular innate immune system 
to autoinflammatory diseases. Cell 
117, 561–574.
Maruta, K., Miyamoto, H., Hamada, 
T., Ogawa, M., Taniguchi, H., and 
Yoshida, S. (1998). Entry and intra-
cellular growth of Legionella dumof-
fii in alveolar epithelial cells. Am. J. 
Respir. Crit. Care Med. 157(Pt 1), 
1967–1974.
Matsiota-Bernard, P., Lefebre, C., Sedqui, 
M., Cornillet, P., and Guenounou, 
M.(1993). Involvement of tumor 
necrosis factor alpha in intracellular 
multiplication of Legionella pneu-
mophila in human monocytes. Infect. 
Immun. 61, 4980–4983.
Molmeret, M., Zink, S. D., Han, L., Abu-
Zant, A., Asari, R., Bitar, D. M., and 
Abu Kwaik, Y. (2004). Activation of 
caspase-3 by the Dot/Icm virulence 
system is essential for arrested bio-
genesis of the Legionella-containing 
phagosome. Cell. Microbiol. 6, 33–48.
Nash, T. W., Libby, D. M., and Horwitz, 
M. A. (1984). Interaction between 
the legionnaires’ disease bacterium 
(Legionella pneumophila) and human 
alveolar macrophages. Influence of 
antibody, lymphokines, and hydrocor-
tisone. J. Clin. Invest. 74, 771–782.
Nash, T. W., Libby, D. M., and Horwitz, 
M. A. (1988). IFN-gamma-activated 
human alveolar macrophages inhibit 
the intracellular multiplication of 
Legionella pneumophila. J. Immunol. 
140, 3978–3981.
Neumeister, B. (2004). Intracellular multi-
plication of Legionella species and the 
influence of amoebae on their intrac-
ellular growth in human monocytes: 
mono mac 6 cells and Acanthamoeba 
castellanii as suitable in vitro models. 
Methods Mol. Biol. 268, 141–151.
Neumeister, B., Bach, V., Faigle, M., and 
Northoff, H. (2001). Induction of 
iNOS in human monocytes infected 
with different Legionella species. FEMS 
Microbiol. Lett. 202, 31–38.
Neumeister, B., Schoniger, S., Faigle, M., 
Eichner, M., and Dietz, K. (1997). 
Multiplication of different Legionella 
species in Mono Mac 6 cells and 
in Acanthamoeba castellanii. Appl. 
Environ. Microbiol. 63, 1219–1224.
Park, D. R., and Skerrett, S. J. (1996). 
IL-10 enhances the growth of 
Hartmannella vermiformis in aquatic 
biofilms grown on plasticized polyvi-
nyl chloride. Appl. Environ. Microbiol. 
70, 6826–6833.
Lettinga, K. D., Verbon, A., Weverling, G. 
J., Schellekens, J. F., Den Boer, J. W., 
Yzerman, E. P., Prins, J., Boersma, W. 
G., van Ketel, R. J., Prins, J. M., and 
Speelman, P. (2002). Legionnaires’ 
disease at a Dutch flower show: prog-
nostic factors and impact of therapy. 
Emerging Infect. Dis. 8, 1448–1454.
Lettinga, K. D., Weijer, S., Speelman, 
P., Prins, J. M., Van Der Poll, T., and 
Verbon, A. (2003). Reduced inter-
feron-gamma release in patients 
recovered from Legionnaires’ disease. 
Thorax 58, 63–67.
Li, J., and Yuan, J. (2008). Caspases in 
apoptosis and beyond. Oncogene 27, 
6194–6206.
Liang, J. L., Dziuban, E. J., Craun, G. F., 
Hill, V., Moore, M. R., Gelting, R. J., 
Calderon, R. L., Beach, M. J., Roy, S. 
L., and Centers for Disease Control 
and Prevention (CDC). (2006). 
Surveillance for waterborne disease 
and outbreaks associated with drink-
ing water and water not intended for 
drinking – United States, 2003–2004. 
MMWR Surveill. Summ. 55, 31–65.
Liles, M.R., Scheel, T. A., and Cianciotto, 
N. P. (2000). Discovery of a nonclassi-
cal siderophore, legiobactin, produced 
by strains of Legionella pneumophila. 
J. Bacteriol. 182, 749–757.
Liston, P., Roy, N., Tamai, K., Lefebvre, 
C., Baird, S., Cherton-Horvat, G., 
Farahani, R., McLean, M., Ikeda, J. 
E., MacKenzie, A., and Korneluk, R. 
G. (1996). Suppression of apoptosis 
in mammalian cells by NAIP and a 
related family of IAP genes. Nature 
379, 349–353.
Lomma, M., Dervins-Ravault, D., 
Rolando, M., Nora, T., Newton, H. J., 
Samson, F. M., Sahr, T., Gomez-Valero, 
L., Jules, M., Hartland, E. L., and 
Buchrieser, C. (2010). The Legionella 
pneumophila F-box protein Lpp2082 
(AnkB)  modulates ubiquitination of 
the host protein parvin B and pro-
motes intracellular replication. Cell. 
Microbiol. 12, 1272–1291.
Losick, V. P., and Isberg, R. R. (2006). 
NF-kappaB translocation prevents 
host cell death after low-dose chal-
lenge by Legionella pneumophila. J. 
Exp. Med. 203, 2177–2189.
Marra, A., Horwitz, M. A., and Shuman, 
H. A. (1990). The HL-60 model for the 
interaction of human macrophages 
with the Legionnaires’ disease bacte-
rium. J. Immunol. 144, 2738–2744.
Marston, B. J., Lipman, H. B., and 
Breiman, R. F. (1994). Surveillance for 
Legionnaires’ disease. Risk factors for 
morbidity and mortality. Arch. Intern. 
Med. 154, 2417–2422.
Hannen, E. J., Rijkers, G. T., van 
Velzen-Blad, H., and de Jongh, B. M. 
(2009). Deficient mannose-binding 
lectin-mediated complement activa-
tion despite mannose-binding lectin-
sufficient genotypes in an outbreak of 
Legionella pneumophila pneumonia. 
Hum. Immunol. 70, 125–129.
Horwitz, M. A. (1983a). Formation of a 
novel phagosome by the Legionnaires’ 
disease bacterium (Legionella pneu-
mophila) in human monocytes. J. Exp. 
Med. 158, 1319–1331.
Horwitz, M. A. (1983b). The Legionnaires’ 
disease bacterium (Legionella pneu-
mophila) inhibits phagosome– 
lysosome fusion in human monocytes. 
J. Exp. Med. 158, 2108–2126.
Horwitz, M. A. (1984). Phagocytosis of 
the Legionnaires’ disease bacterium 
(Legionella pneumophila) occurs by a 
novel mechanism: engulfment within 
a pseudopod coil. Cell 36, 27–33.
Horwitz, M. A., and Maxfield, F. R. 
(1984). Legionella pneumophila inhib-
its acidification of its phagosome in 
human monocytes. J. Cell Biol. 99, 
1936–1943.
Horwitz, M. A., and Silverstein, S. C. 
(1980). Legionnaires’ disease bacterium 
(Legionella pneumophila) multiples 
intracellularly in human monocytes. 
J. Clin. Invest. 66, 441–450.
Horwitz, M. A., and Silverstein, S. C. 
(1981a). Activated human monocytes 
inhibit the intracellular multiplication 
of Legionnaires’ disease bacteria. J. 
Exp. Med. 154, 1618–1635.
Horwitz, M. A., and Silverstein, S. 
C. (1981b). Interaction of the 
Legionnaires’ disease bacterium 
(Legionella pneumophila) with human 
phagocytes. I. L. pneumophila resists 
killing by polymorphonuclear leuko-
cytes, antibody, and complement. J. 
Exp. Med. 153, 386–397.
Isberg, R. R., O’Connor, T. J., and 
Heidtman, M. (2009). The Legionella 
pneumophila replication vacuole: 
making a cosy niche inside host cells. 
Nat. Rev. Microbiol. 7, 13–24.
Ivanov, S. S., and Roy, C. R. (2009). 
Modulation of ubiquitin dynamics 
and suppression of DALIS forma-
tion by the Legionella pneumophila 
Dot/Icm system. Cell. Microbiol. 11, 
261–278.
Janeway, C. A. Jr., and Medzhitov, R. 
(2002). Innate immune recognition. 
Annu. Rev. Immunol. 20, 197–216.
Kagan, J. C., and Roy, C. R. (2002). 
Legionella phagosomes intercept 
vesicular traffic from endoplasmic 
reticulum exit sites. Nat. Cell Biol. 4, 
945–954.
Kuiper, M. W., Wullings, B. A., Akkermans, 
A. D., Beumer, R. R., and van der 
Kooij, D. (2004). Intracellular prolif-
eration of Legionella pneumophila in 
steam turbine condenser. Science 205, 
690–691.
Friedman, H., Yamamoto, Y., and Klein, 
T. W. (2002). Legionella pneumophila 
pathogenesis and immunity. Semin. 
Pediatr. Infect. Dis. 13, 273–279.
Gao, L. Y., and Abu Kwaik, Y. (1999a). 
Activation of caspase 3 during 
Legionella pneumophila-induced apop-
tosis. Infect. Immun. 67, 4886–4894.
Gao, L. Y., and Abu Kwaik, Y. (1999b). 
Apoptosis in macrophages and  alveolar 
epithelial cells during early stages of 
infection by Legionella pneumophila 
and its role in cytopathogenicity. 
Infect. Immun. 67, 862–870.
Gebran, S. J., Newton, C., Yamamoto, Y., 
Widen, R., Klein, T. W., and Friedman, 
H. (1994). Macrophage permissiveness 
for Legionella pneumophila growth 
modulated by iron. Infect. Immun. 
62, 564–568.
Goldstein, E., Lippert, W., and Warshauer, 
D. (1974). Pulmonary alveolar mac-
rophage. Defender against bacterial 
infection of the lung. J. Clin. Invest. 
54, 519–528.
Green, G. M. (1970). The J. Burns 
Amberson Lecture – in defense of 
the lung. Am. Rev. Respir. Dis. 102, 
691–703.
Hatakeyama, S., Yada, M., Matsumoto, 
M., Ishida, N., and Nakayama, K. I. 
(2001). U box proteins as a new fam-
ily of  ubiquitin-protein ligases. J. Biol. 
Chem. 276, 33111–33120.
Hawn, T. R., Berrington, W. R., Smith, I. 
A., Uematsu, S., Akira, S., Aderem, A., 
Smith, K. D., and Skerrett, S. J. (2007). 
Altered inflammatory responses in 
TLR5-deficient mice infected with 
Legionella pneumophila. J. Immunol. 
179, 6981–6987.
Hawn, T. R., Verbon, A., Lettinga, K. 
D., Zhao, L. P., Li, S. S., Laws, R. J. 
Skerrett, S. J., Beutler, B., Schroeder, 
L., Nachman, A., Ozinsky, A., Smith, K. 
D., and Aderem, A. (2003). A common 
dominant TLR5 stop codon polymor-
phism abolishes flagellin signaling 
and is associated with susceptibility 
to legionnaires’ disease. J. Exp. Med. 
198, 1563–1572.
Hawn, T. R., Verbon, A., Janer, M., Zhao, L. 
P., Beutler, B., and Aderem, A. (2005). 
Toll-like receptor 4 polymorphisms 
are associated with resistance to 
Legionnaires’ disease. Proc. Natl. Acad. 
Sci. U.S.A. 102, 2487–2489.
Hayashi, F., Smith, K. D., Ozinsky, A., 
Hawn, T. R., Yi, E. C., Goodlett, D. R., 
Eng, J. K., Akira, S., Underhill, D. M., 
and Aderem, A. (2001). The innate 
immune response to bacterial flagel-
lin is mediated by Toll-like receptor 5. 
Nature 410, 1099–1103.
Herpers, B. L., Yzerman, E. P., de Jong, 
B. A., Bruin, J. P., Lettinga, K. D., 
Kuipers, S., Den Boer, J. W., van 
Frontiers in Microbiology | Cellular and Infection Microbiology  December 2010 | Volume 1 | Article 133 | 8
Khweek and Amer The interaction of Legionella pneumophila with phagocytes
Yu, V. L., Plouffe, J. F., Pastoris, M. C., 
Stout, J. E., Schousboe, M., Widmer, 
A., Summersgill, J., File, T., Heath, C. 
M., Paterson, D. L., and Chereshsky, 
A. (2002). Distribution of Legionella 
species and serogroups isolated by 
culture in patients with sporadic 
community-acquired legionellosis: 
an international collaborative survey. 
J. Infect. Dis. 186, 127–128.
Ziegler-Heitbrock, H. W., Thiel, E., 
Futterer, A., Herzog, V., Wirtz, A., and 
Riethmuller, G. (1988). Establishment 
of a human cell line (Mono Mac 6) 
with characteristics of mature mono-
cytes. Int. J. Cancer 41, 456–461.
Zink, S. D., Pedersen, L., Cianciotto, N. 
P., and Abu-Kwaik, Y. (2002). The 
Dot/Icm type IV secretion system 
of Legionella pneumophila is essen-
tial for the induction of apoptosis in 
human macrophages. Infect. Immun. 
70, 1657–1663.
Conflict of Interest Statement: The 
authors declare that the research was con-
ducted in the absence of any commercial or 
financial relationships that could be con-
strued as a potential conflict of interest.
Received: 02 August 2010; accepted: 16 
November 2010; published online: 28 
December 2010.
Citation: Khweek AA and Amer A (2010) 
Replication of Legionella pneumophila 
in human cells: why are we susceptible? 
Front. Microbio. 1:133. doi: 10.3389/
fmicb.2010.00133
This article was submitted to Frontiers in 
Cellular and Infection Microbiology, a spe-
cialty of Frontiers in Microbiology.
Copyright © 2010 Khweek and Amer. This 
is an open-access article subject to an exclu-
sive license agreement between the authors 
and the Frontiers Research Foundation, 
which permits unrestricted use, distribu-
tion, and reproduction in any medium, 
provided the original authors and source 
are credited.
Takeda, K., Kaisho, T., and Akira, S. 
(2003). Toll-like receptors. Annu. Rev. 
Immunol. 21, 335–376.
Turner, M. W. (1996). Mannose-binding 
lectin: the pluripotent molecule of 
the innate immune system. Immunol. 
Today 17, 532–540.
Underhill, D. M., Ozinsky, A., Smith, K. D. 
and Aderem, A. (1999). Toll-like recep-
tor-2 mediates  mycobacteria-induced 
proinflammatory signaling in macro-
phages. Proc. Natl. Acad. Sci. U.S.A. 96, 
14459–14463.
Vinzing, M., Eitel, J., Lippmann, J., 
Hocke, A. C., Zahlten, J., Slevogt, H., 
N’guessan, P. D., Günther, S., Schmeck, 
B., Hippenstiel, S., Flieger, A., Suttorp, 
N., and Opitz, B. (2008). NAIP and 
Ipaf control Legionella pneumophila 
replication in human cells. J. Immunol. 
180, 6808–6815.
Viswanathan, V. K., Edelstein, P. H., Pope, 
C. D., and Cianciotto, N. P. (2000). The 
Legionella pneumophila iraAB locus is 
required for iron assimilation, intrac-
ellular infection, and virulence. Infect. 
Immun. 68, 1069–1079.
Walsh, J. G., Cullen, S. P., Sheridan, C., 
Luthi, A. U., Gerner, C., and Martin, 
S. J. (2008). Executioner caspase-3 
and caspase-7 are functionally distinct 
proteases. Proc. Natl. Acad. Sci. U.S.A. 
105, 12815–12819.
Watnick, P., and Kolter, R. (2000). Biofilm, 
city of microbes. J. Bacteriol. 182, 
2675–2679.
Winn, W. C. Jr., and Myerowitz, R. 
L. (1981). The pathology of the 
Legionella pneumonias. A review of 74 
cases and the literature. Hum. Pathol. 
12, 401–422.
Wright, E. K., Goodart, S. A., Growney, 
J. D., Hadinoto, V., Endrizzi, M. G., 
Long, E. M., Sadigh, K., Abney, A. L., 
Bernstein-Hanley, I., and Dietrich, W. 
F. (2003). Naip5 affects host suscep-
tibility to the intracellular pathogen 
Legionella pneumophila. Curr. Biol. 
13, 27–36.
Rowbotham, T. J. (1980). Preliminary report 
on the pathogenicity of Legionella pneu-
mophila for freshwater and soil amoe-
bae. J. Clin. Pathol. 33, 1179–1183.
Rowbotham, T. J. (1986). Current views 
on the relationships between amoebae, 
legionellae and man. Isr. J. Med. Sci. 
22, 678–689.
Santic, M., Asare, R., Doric, M., and 
Abu Kwaik, Y. (2007). Host-dependent 
trigger of caspases and apoptosis by 
Legionella pneumophila. Infect. Immun. 
75, 2903–2913.
Santic, M., Molmeret, M., and Abu Kwaik, 
Y. (2005). Maturation of the Legionella 
 pneumophila-containing phagosome 
into a phagolysosome within gamma 
interferon-activated macrophages. 
Infect. Immun. 73, 3166–3171.
Schmeck, B., N’Guessan, P. D., Ollomang, 
M., Lorenz, J., Zahlten, J., Opitz, 
B., Flieger, A., Suttorp, N., and 
Hippenstiel, S. (2007). Legionella 
pneumophila-induced NF-kappaB- 
and MAPK-dependent cytokine 
release by lung epithelial cells. Eur. 
Respir. J. 29, 25–33.
Sethi, K. K., and Brandis, H. (1983). 
Direct demonstration and isolation of 
Legionella pneumophila (serogroup 1) 
from bathroom water specimens in a 
hotel. Zentralbl. Bakteriol. Mikrobiol. 
Hyg. B 177, 402–405.
Spitalny, K. C., Vogt, R. L., Orciari, L. A., 
Witherell, L. E., Etkind, P., and Novick, 
L. F. (1984). Pontiac fever associated 
with a whirlpool spa. Am. J. Epidemiol. 
120, 809–817.
Swanson, M. S., and Isberg, R. R. (1995). 
Association of Legionella pneumophila 
with the macrophage endoplas-
mic reticulum. Infect. Immun. 63, 
3609–3620.
Takahashi, R., Deveraux, Q., Tamm, I., 
Welsh, K., Assa-Munt, N., Salvesen, 
G. S., and Reed, J. C. (1998). A sin-
gle BIR domain of XIAP  sufficient 
for inhibiting caspases. J. Biol. Chem. 
273, 7787–7790.
Legionella pneumophila in human 
mononuclear phagocytes and 
reverses the protective effect of 
IFN-gamma: differential responses 
of blood monocytes and alveolar 
macrophages. J. Immunol. 157, 
2528–2538.
Payne, N. R., and Horwitz, M. A. (1987). 
Phagocytosis of Legionella pneu-
mophila is mediated by human 
monocyte complement receptors. J. 
Exp. Med. 166, 1377–1389.
Pearlman, E., Jiwa, A. H., Engleberg, N. C., 
and Eisenstein, B. I. (1988). Growth 
of Legionella pneumophila in a human 
macrophage-like (U937) cell line. 
Microb. Pathog. 5, 87–95.
Poyet, J.L., Srinivasula, S. M., Tnani, M., 
Razmara, M., Fernandes-Alnemri, T., 
and Alnemri, E. S. (2001). Identification 
of Ipaf, a human caspase-1-activating 
protein related to Apaf-1. J. Biol. Chem. 
276, 28309–28313.
Price, C. T., Al-Khodor, S., Al-Quadan, 
T., Santic, M., Habyarimana, F., 
Kalia, A., and Kwaik, Y. A. (2009). 
Molecular mimicry by an F-box effec-
tor of Legionella pneumophila hijacks 
a conserved polyubiquitination 
machinery within macrophages and 
protozoa. PLoS Pathog. 5, e1000704. 
doi: 10.1371/journal.ppat.1000704.
Radtke, A. L., and O’Riordan, M. X. 
(2006). Intracellular innate resistance 
to bacterial pathogens. Cell. Microbiol. 
8, 1720–1729.
Rogers, J., Dowsett, A. B., Dennis, P. J., 
Lee, J. V., and Keevil, C. W. (1994). 
Influence of plumbing materials 
on biofilm formation and growth 
of Legionella pneumophila in pota-
ble water systems. Appl. Environ. 
Microbiol. 60, 1842–1851.
Rovera, G., Santoli, D., and Damsky, C. 
(1979). Human promyelocytic leuke-
mia cells in culture differentiate into 
macrophage-like cells when treated 
with a phorbol diester. Proc. Natl. 
Acad. Sci. U.S.A. 76, 2779–2783.
